These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13820202)

  • 21. Treatment of acute and chronic lead poisoning with disodium calcium versenate.
    WADE JF; BURNUM JF
    Ann Intern Med; 1955 Feb; 42(2):251-9. PubMed ID: 14350457
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of the CaNa2 EDTA Pb-mobilization test to detect occult lead nephropathy.
    Wedeen RP
    Uremia Invest; 1985-1986; 9(2):127-30. PubMed ID: 3939486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on the effect of calcium thiosulfate and dicalcium- and disodium versenate. II. Protective action against lead and oxalate poisoning and alteration of membrane permeability].
    KLINGER W; KERSTEN L
    Acta Biol Med Ger; 1961; 6():498-508. PubMed ID: 14457026
    [No Abstract]   [Full Text] [Related]  

  • 24. Chelation therapy in lead nephropathy questioned.
    Sawyer HJ
    Arch Intern Med; 1985 Oct; 145(10):1927. PubMed ID: 3929710
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mixed poisoning caused by insecticides (organic mercurials and dinitro-o-cresol). Trial therapy by calcium versenate].
    LOB M
    Z Unfallmed Berufskr; 1960 Mar; 53():53-7. PubMed ID: 14417751
    [No Abstract]   [Full Text] [Related]  

  • 26. The comparison of BAL (2, 3-dimercaptopropanol) and Ca EDTA (calcium ethylene diamine tetra acetate) in the treatment of lead encephalopathy.
    BRADLEY JE; BALDWIN RW; MENON G
    Bull Georgetown Univ Med Cent; 1957 Jan; 10(3):79-82. PubMed ID: 13404369
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the effect of calcium thiosulfate and dicalcium and disodium calcium versenate. I. Degree of ionization, acute and chronic toxicity].
    KLINGER W; KERSTEN L
    Acta Biol Med Ger; 1961; 6():447-52. PubMed ID: 14457025
    [No Abstract]   [Full Text] [Related]  

  • 28. [How to examine ... a patient of nephroarteriosclerosis caused by chronic lead poisoning].
    IZAR G
    Minerva Med; 1960 May; 51():1893-4. PubMed ID: 14406214
    [No Abstract]   [Full Text] [Related]  

  • 29. Gout and crystal-related nephropathy.
    Cameron JS; Simmonds HA
    Contrib Nephrol; 1979; 16():147-53. PubMed ID: 467064
    [No Abstract]   [Full Text] [Related]  

  • 30. Lead nephropathy, gout, and hypertension.
    Batuman V
    Am J Med Sci; 1993 Apr; 305(4):241-7. PubMed ID: 8475950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of lead in gout nephropathy.
    Batuman V; Maesaka JK; Haddad B; Tepper E; Landy E; Wedeen RP
    N Engl J Med; 1981 Feb; 304(9):520-3. PubMed ID: 6779160
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aspects of the elimination of lead in saturnism during treatment with Versenate].
    PETTINATI L; GRIBAUDO C; COSCIA GC; SARACCO C
    Folia Med (Napoli); 1962 Feb; 45():89-104. PubMed ID: 14486040
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of chronic lead-poisoning with calcium disodium versenate.
    MARKUS AC; SPENCER AG
    Br Med J; 1955 Oct; 2(4944):883-5. PubMed ID: 13250247
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ionization capacity of versenate calcium disodium].
    VERGES G
    Rev Esp Fisiol; 1960 Jun; 16():149-54. PubMed ID: 13780864
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone lead and the diagnosis of lead nephropathy.
    Wedeen RP; Van de Vyver FL; D'Haese PC; Visser WJ; Elseviers MM; Knippenberg LJ; Lamberts LV; De Broe ME; Batuman V; Schidlovsky G
    Contrib Nephrol; 1988; 64():102-8. PubMed ID: 3141113
    [No Abstract]   [Full Text] [Related]  

  • 36. [Problems of therapy with calcium versenate].
    KLINGER W; HOFMANN H
    Z Arztl Fortbild (Jena); 1961 Aug; 55():935-7. PubMed ID: 14457023
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of lead on the kidney.
    Malcolm D
    Trans Soc Occup Med; 1970 Apr; 20(2):50-3. PubMed ID: 5432200
    [No Abstract]   [Full Text] [Related]  

  • 38. [Atypical digestive manifestations of non-occupational lead poisoning. Results of treatment by chelators].
    de FALLOIS
    Arch Mal Appar Dig Mal Nutr; 1959 Oct; 48():1126-32. PubMed ID: 13821449
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute versenate nephrosis; occurring as the result of treatment for lead intoxication.
    REUBER MD; BRADLEY JE
    JAMA; 1960 Sep; 174():263-9. PubMed ID: 14437478
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effects of penicillamine and versenate in the treatment of Wilson's disease and lead poisoning].
    SEIGNETTE WT; HAANEN CA; JANSEN AP; MAJOOR CL
    Folia Med Neerl; 1959 Jun; 2():65-78. PubMed ID: 14444631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.